Moreover, the level of Sp1 was increased upon the treatment of TGF-β1 in two lung cancer cells (Figure 2A), suggesting that miR-29c might function as a tumor suppressor and impair the TGF-β1-induced EMT. The gene discussed is SP1; the disease is lung carcinoma.